Disruption is evident throughout society these days, and the healthcare industry has not been spared. Look no further than the recent CVS deal to acquire Aetna or UnitedHealth’s Optum acquisition of 300 medical clinics from DaVita.
Participating practices point to a number of successes attributable to OCM, even as they grapple with challenges presented by the model.
Recent changes to CMS’s Hospital Outpatient Prospective Payment System (OPPS) rule for CY 2018 have created a stir across the healthcare industry due to the profound impact on organizations participating in the 340B Drug Pricing Program.
CMS has finalized the CY 2018 Hospital Outpatient Prospective Payment System (OPPS) rule, confirming changes to the 340B Drug Pricing Program that were proposed earlier this year.
CMS released its proposal for CY 2018 Hospital Outpatient Prospective Payment System (OPPS) payment rules, containing significant changes to reimbursement for hospitals participating in the 340B Drug Pricing Program.
To maintain a competitive edge while providing patient-centered care, health systems and their aligned oncology programs need to approach service line planning from an enterprise, regional, and programmatic level.
CMS identifies final rule and the 98 markets mandated to participate in a bundled payment program for cardiac care, as well as surgical hip and femur fracture care.
How to determine whether your cardiac service line meets the requirements for a TAVR program.
Rationalization is an approach that can help a health system optimize its resources and enhance patient access across the entire organization.
Page 1 of 13